Tuesday, July 14, 2026
VideoAdmin
NewsWhite
Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
BUSINESS
Unverified

Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker

June 19, 2026·Source: CNBC·45 views

Share This Article

While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver

Share This Article

Originally reported by CNBC. Read the original article

Related Articles

‘Beijing is laughing’ at US-Mexico-Canada stalled trade talks
BUSINESS

‘Beijing is laughing’ at US-Mexico-Canada stalled trade talks

A US trade expert says the US, Mexico, and Canada need to hold trilateral talks to get a cross-border trade deal signed.

Al Jazeera·13h ago
Trump's Hormuz toll plans bring oil supply risks back in spotlight
BUSINESS

Trump's Hormuz toll plans bring oil supply risks back in spotlight

While the proposed levy would raise shipping costs, an escalating conflict could remove barrels from the market altogether.

CNBC·14h ago
Japan’s bond market is back in play after decades in the wilderness
BUSINESS

Japan’s bond market is back in play after decades in the wilderness

JGBs have been selling off amid policy normalization and concerns over Tokyo's spending plans, but experts say that they deserve another look from investors.

CNBC·19h ago
A streaming stock risks diving below its key support level this week. Here's what else Jay Woods is watching
BUSINESS

A streaming stock risks diving below its key support level this week. Here's what else Jay Woods is watching

NYSE insider Jay Woods is keeping an eye on Netflix in advance of its latest financial results due out later this week. Here's what else he's watching.

CNBC·23h ago